Abstract
Pulmonary embolism (PE) is a life-threatening condition and a leading cause of morbidity and mortality. There have been many advances in the field of PE in the last few years, requiring a careful assessment of their impact on patient care. However, variations in recommendations by different clinical guidelines, as well as lack of robust clinical trials, make clinical decisions challenging. The Pulmonary Embolism Response Team Consortium is an international association created to advance the diagnosis, treatment, and outcomes of patients with PE. In this consensus practice document, we provide a comprehensive review of the diagnosis, treatment, and follow-up of acute PE, including both clinical data and consensus opinion to provide guidance for clinicians caring for these patients.
Document Type
Review
Publication Date
6-11-2019
Digital Object Identifier (DOI)
https://doi.org/10.1177/1076029619853037
Related Content
Supplemental material for this article is available online.
Repository Citation
Rivera-Lebron, Belinda; McDaniel, Michael; Ahrar, Kamran; Alrifai, Abdulah; Dudzinski, David M.; Fanola, Christina; Blais, Danielle; Janicke, David; Melamed, Roman; Mohrien, Kerry; Rozycki, Elizabeth; Ross, Charles B.; Klein, Andrew J.; Rali, Parth; Teman, Nicholas R.; Yarboro, Leoara; Ichinose, Eugene; Sharma, Aditya M.; Bartos, Jason A.; Elder, Mahir; Keeling, Brent; Palevsky, Harold; Naydenov, Soophia; Sen, Parijat; Amoroso, Nancy; Rodriguez-Lopez, Josanna M.; Davis, George A.; Rosovsky, Rachel; Rosenfield, Kenneth; Kabrhel, Christopher; Horowitz, James; Giri, Jay S.; Tapson, Victor; Channick, Richard; and PERT Consortium, "Diagnosis, Treatment and Follow Up of Acute Pulmonary Embolism: Consensus Practice from the PERT Consortium" (2019). Pharmacy Practice and Science Faculty Publications. 46.
https://uknowledge.uky.edu/pps_facpub/46
Supplementary Material
Notes/Citation Information
Published in Clinical and Applied Thrombosis/Hemostasis, v. 25, p. 1-16.
© The Author(s) 2019
This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).